rs2269066
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001735.3(C5):c.4017+39G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 1,550,100 control chromosomes in the GnomAD database, including 11,916 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.17 ( 2975 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8941 hom. )
Consequence
C5
NM_001735.3 intron
NM_001735.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.132
Publications
26 publications found
Genes affected
C5 (HGNC:1331): (complement C5) This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
C5 Gene-Disease associations (from GenCC):
- complement component 5 deficiencyInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.166 AC: 25315AN: 152102Hom.: 2970 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25315
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.112 AC: 28263AN: 251228 AF XY: 0.107 show subpopulations
GnomAD2 exomes
AF:
AC:
28263
AN:
251228
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.103 AC: 143775AN: 1397880Hom.: 8941 Cov.: 25 AF XY: 0.101 AC XY: 70580AN XY: 699534 show subpopulations
GnomAD4 exome
AF:
AC:
143775
AN:
1397880
Hom.:
Cov.:
25
AF XY:
AC XY:
70580
AN XY:
699534
show subpopulations
African (AFR)
AF:
AC:
10305
AN:
31176
American (AMR)
AF:
AC:
2589
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
AC:
1816
AN:
25776
East Asian (EAS)
AF:
AC:
8521
AN:
39372
South Asian (SAS)
AF:
AC:
3808
AN:
85088
European-Finnish (FIN)
AF:
AC:
6153
AN:
53352
Middle Eastern (MID)
AF:
AC:
416
AN:
5652
European-Non Finnish (NFE)
AF:
AC:
103661
AN:
1054578
Other (OTH)
AF:
AC:
6506
AN:
58228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
5230
10459
15689
20918
26148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3678
7356
11034
14712
18390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.167 AC: 25361AN: 152220Hom.: 2975 Cov.: 32 AF XY: 0.162 AC XY: 12056AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
25361
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
12056
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
13485
AN:
41496
American (AMR)
AF:
AC:
1318
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
248
AN:
3468
East Asian (EAS)
AF:
AC:
1098
AN:
5180
South Asian (SAS)
AF:
AC:
222
AN:
4828
European-Finnish (FIN)
AF:
AC:
1160
AN:
10612
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7301
AN:
68020
Other (OTH)
AF:
AC:
298
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1019
2038
3058
4077
5096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
557
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.